iSign Solutions Inc. - Quarter Report: 2016 June (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

X	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

iSign Solutions Inc.

(Exact name of registrant as specified in its charter)

          (Address of principal executive offices)                  (Zip Code)

Registrant's telephone number, including area code

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Section 12b-2 of the exchange Act)

Number of shares outstanding of the issuer's Common Stock, as of August 15, 2016: 5,498,246

 

INDEX

Item 1.  Financial Statements

iSign Solutions Inc.

Condensed Consolidated Balance Sheets

 (In thousands)

 

See accompanying notes to these Condensed Consolidated Financial Statements

iSign Solutions Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In thousands, except per share amounts)

 

iSign Solutions Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

 

iSign Solutions Inc.

Condensed Consolidated Statements of Cash Flows (Continued)

(Unaudited)

(In thousands)

 

1.	Nature of Business and Summary of Significant Accounting Policies

On January 21, 2016, iSign Solutions Inc. (the "Company" or "iSign") filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the "Certificate of Amendment") with the Secretary of State of the State of Delaware to effect a 1-for-1,250 reverse split of the Company's outstanding shares of common stock.  The reverse split became effective on January 22, 2016. The information with respect to common stock for the period ended June 30, 2015 has been retroactively restated to give effect to the 1-for-1,250 reverse split.

iSign Solutions Inc. and its subsidiary is a leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective management and authentication of document-based transactions. iSign's solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and various options for biometric authentication. These solutions are available across virtually all enterprise, desktop and mobile environments as a seamlessly integrated platform for both ad-hoc and fully automated transactions. iSign's platform can be deployed both on premise and as a cloud-based ("SaaS") service, with the ability to easily transition between deployment models. The Company is headquartered in Redwood Shores, California. The Company's products include SignatureOne® Ceremony™ Server, the iSign® suite of products and services, including iSign® Enterprise and iSign® Console™, and Sign-it® programs.

The financial information contained herein should be read in conjunction with the Company's consolidated audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2015.

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("GAAP") for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company's results of operations and cash flows for the periods presented. The Company's interim results are not necessarily indicative of the results to be expected for the entire year.

Going Concern

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant cumulative losses since its inception and, at June 30, 2016, the Company's accumulated deficit was $129,395. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of June 30, 2016, the Company's cash balance was $455. These factors raise substantial doubt about the Company's ability to continue as a going concern.

There can be no assurance that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

1.	Nature of Business and Summary of Significant Accounting Policies (continued)

Accounting Changes and Recent Accounting Pronouncements

In January 2016, the FASB issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. ASU 2016-01 requires all financial assets and liabilities not accounted for under the equity method to be measured at fair value with the changes in fair value recognized in net income. The amendments in this update also require an entity to separately present in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. In addition, the amendments in this update supersede the requirement to disclose the methods and significant assumptions used in calculating the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet for public business entities. Early adoption is not permitted except for the comprehensive income presentation requirement, and the updated guidance requires a prospective application with a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The guidance is effective for annual periods after December 15, 2017, and we are currently in the process of evaluating the impact of this new guidance.

In March 2016 the FASB issued ASU No. 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 provides for simplification involving several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. In addition to these simplifications, ASU 2016-09 also eliminates the guidance in Topic 718 that was indefinitely deferred shortly after the issuance of FASB Statement No. 123 (revised 2004), Share-Based Payment. Early adoption is permitted and the application of the guidance is different for each update included within ASU 2016-09. The guidance is effective for annual periods after December 15, 2016, and we are currently in the process of evaluating the impact of this new guidance.

In May 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-12 Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients. ASU 2016-12 provides for improvements and practical expedients for specific areas of Topic 606. In April 2016, the FASB issued ASU No. 2016-10 Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 provides for clarification of two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance. In March 2016, the FASB issued ASU No. 2016-08Revenue from Contracts with Customers (Topic 606) - Principal versus Agent Considerations (Reporting Revenue Gross versus Net). ASU No. 2016-08 requires an entity to determine whether the nature of its promise to provide goods or services to a customer is performed in a principal or agent capacity and to recognize revenue in a gross or net manner based on its principal/agent designation.

ASUs 2016-12, 2016-10 and 2016-08 allow for companies to choose to apply the standard retrospectively to each prior reporting period presented (full retrospective application) or retrospectively with the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings of the annual reporting period that includes the date of initial application (modified retrospective application). Each guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Early application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. We are currently in the process of evaluating these guidance updates.

iSign is in the process of evaluating the impact of this new guidance on the Company's financial position, results of operations and cash flows.

The following table summarizes accounts receivable and revenue concentrations:

3.	Intangible assets

The Company performs an intangible asset impairment analysis at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in the event the net book value of such assets exceeded the future undiscounted cash flows attributable to such assets.

Management completed an analysis of the Company's intangible assets as of December 31, 2015. Based on that analysis, the Company concluded that no impairment of the carrying value of the intangible assets existed. The Company believes that no events or circumstances changed during the three and six months ended June 30, 2016 that would impact this conclusion.

Amortization of intangible assets costs was $80 and $161 for the three and six-month periods ended June 30, 2016 and $86 and $173 for the three and six-month periods ended June 30, 2015, respectively.

The following table summarizes the patents:

4.	Net Loss per Share

The Company calculates basic net loss per share based on the weighted average number of shares outstanding, and when applicable, diluted net income per share, which is based on the weighted average number of shares and potential dilutive shares outstanding.

The Company's Preferred Shareholders converted all of their Preferred Stock into shares of Common Stock on May 19, 2016. The following table lists shares and warrants that were excluded from the calculation of diluted earnings per share as the exercise of such options and warrants and the conversion of such preferred shares would be anti-dilutive:

5.

Debt

Short-term notes payable:

In the fourth quarter of 2015, the Company entered into unsecured convertible promissory note purchase agreements with investors and affiliates of the Company aggregating $1,268 in cash. Promissory notes with a principal amount of $1,068 plus accrued interest converted into shares of our Common Stock on May 19, 2016. 

The notes and accrued interest converted at a price of $1.74 per share into 683 shares of our Common Stock. The holders of the notes also received 854 warrants to purchase 854 shares of Common Stock. Such warrants have a 5 year term and are exercisable at a price of $2.175 per share. The Company ascribed a relative fair value to the warrants using the Black-Scholes-Merton valuation model of $586, which was charged to additional paid-in capital during the quarter ended June 30, 2016.

One promissory note with a principal amount of $190, net of $10 in unamortized discount, remains outstanding as of June 30, 2016. This note bears interest at a rate of 24% per year and is due on August 25, 2016. The note can be converted into shares of our Common Stock at the holder's option for a period of 60 days after maturity, at a conversion price based upon a Company pre-money valuation of $5,000. Upon such conversion, the holder would also receive cash payments, payable from 3% of the revenue received by the Company from its European customer, not to exceed three times the aggregate principal amount of $200.

6.	Derivative Liability

The Company has determined that a contract that would otherwise meet the definition of a derivative but is both (a) indexed to the Company's own stock and (b) classified in stockholders' deficit in the statement of financial position would not be considered a derivative financial instrument. The Company applies a two-step model in determining whether a financial instrument or an embedded feature is indexed to an issuer's own stock and thus able to qualify for the scope exception.

6.	Derivative Liability (continued)

In November and December 2015, the Company entered into unsecured convertible promissory note purchase agreements with investors and affiliates of the Company. The accounting for the unsecured convertible notes, which are convertible into shares of our common stock, requires us to bifurcate the conversion feature and account for it as a derivative liability at the estimated fair value upon issuance.  The Company used a Monte Carlo simulation to value the conversion feature with the following assumptions:

 

		As of June 30, 2016
Common Stock price		$	1.31
Convertible debt principal amount		$	200
Term (years)			0.32
Expected volatility			108	%
Convertible debt interest rate			24	%
Trials (each trial equals 150,000 iterations)			10
Discount to IPO/next round		Based upon a Company pre-money valuation of $5,000

Level 1: Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2: Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3: Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

There were no financial assets or liabilities measured at fair value, with the exception of cash and cash equivalents (level 1) and the above mentioned derivative liability (level 3) as of June 30, 2016 and December 31, 2015, respectively.

Changes in the fair market value of the Level 3 derivative liability for the six-month periods ended June 30, 2016 and June 30, 2015 are as follows:

7.	Equity (Deficit)

Stock-based compensation expense is based on the estimated grant date fair value of the portion of stock-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes-Merton valuation model.

Forfeitures of stock-based payment awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The estimated average forfeiture rate for the three months ended June 30, 2016 and 2015, was approximately 11.89% and 7.54%, respectively, based on historical data.

Valuation and Expense Information:

The weighted-average fair value of stock-based compensation is based on the Black-Scholes-Merton valuation model. Forfeitures are estimated and it is assumed no dividends will be declared.  The estimated fair value of stock-based compensation awards to employees is amortized using the accrual method over the vesting period of the options. The fair value calculations are based on the following assumptions:

There were no stock options granted, and no stock options exercised during the three and six months ended June 30, 2016. The Company granted 29 stock options during the three and six months ended June 30, 2015 at a weighted average exercise price of $28.13 per share. There were no stock options exercised during the three and six months ended June 30, 2015.

The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three and six months ended June 30:

7.	Equity (deficit) (continued)

A summary of option activity under the Company's plans for the six months ended June 30, 2016 and 2015 is as follows:

The following table summarizes significant ranges of outstanding and exercisable options as of June 30, 2016:

A summary of the status of the Company's non-vested shares as of June 30, 2016 is as follows:

As of June 30, 2016, there was a total of $107 of unrecognized compensation expense related to non-vested stock-based compensation arrangements granted under the plans.  The unrecognized compensation expense is expected to be realized over a weighted average period of 1.7 years.

On May 19, 2016, the Company closed an underwritten public offering of 690 shares of common stock at a public offering price of $1.74 per share. In addition, the Company sold 345 warrants, at a public offering price of $0.01 per warrant, to purchase shares of Common Stock. The warrants expire on May 18, 2021 and have an exercise price of $2.175 per share.  The Company raised gross cash proceeds of $1,204 before deducting underwriting discounts and commissions and other offering expenses of $780.  As a result of the consummation of the offering, each series of the Company's outstanding preferred stock, including accrued and unpaid dividends through May 19, 2016, were converted into shares of common stock.

7.	Equity (Deficit) (continued)

As a result of the Amendments to the Certificates of Designations to all classes of Preferred Stock and pursuant to the terms thereof, the conversion price of the Company's Preferred Stock was reduced. The following table summarizes the change in conversion price, the number of shares outstanding as of the conversion date and the number of Common Stock issued upon conversion of the Preferred Stock.

The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

In conjunction with the sale of Common Stock, $1,188 of Short-term debt including accrued interest of $120 was converted into 683 shares of the Company's Common Stock. The Company issued 854 warrants with the conversion of the Short–term debt. The Company ascribed a relative fair value of $586 to the warrants using the Black-Scholes-Merton valuation model, which was charged to additional paid-in capital during the quarter ended June 30, 2016.

In addition to the conversion of the Short-term debt, approximately $498 of deferred compensation including accrued interest of $59 was converted into 286 shares of the Company's Common Stock. The Company issued 352 warrants with the conversion of the deferred compensation. The Company ascribed a relative fair value of $244 to the warrants using the Black-Scholes-Merton valuation model, which was charged to additional paid- in capital during the quarter ended June 30, 2016.

The conversion price of the Short-term debt and deferred compensation was $1.74 per share. The warrants expire on May 18, 2021 and have an exercise price of $2.175.

Information with respect to in-kind dividends issued on the Company's Preferred stock for the three and six-month periods ended June 30, 2016 and June 30, 2015 is as follows:

		Dividends																Beneficial Conversion Feature Related to dividends
		Three Months Ended June 30,								Six Months Ended June 30,								Three Months Ended June 30,								Six Months Ended June 30,
		2016				2015				2016				2015				2016				2015				2016					2015
Series A-1		$	10			$	17			$	29			$	35			$	−			$	−			$	3			$	−
Series B			182				313				519				615				−				−				73				−
Series C			74				127				211				250				−				−				39				13
Series D-1			108				179				309				324				−				−				78				16
Series D-2			85				149				245				292				−				−				52				−
Total		$	459			$	785			$	1,313			$	1,516			$	−			$	−			$	245			$	29

 

7.	Equity (Deficit) (continued)

A summary of the warrant activity for the six months ended June 30 is as follows:

A summary of the status of the warrants outstanding and exercisable as of June 30, 2016 is as follows:

Forward Looking Statements

Certain statements contained in this quarterly report on Form 10-Q, including, without limitation, statements containing the words "believes", "anticipates", "hopes", "intends", "expects", and other words of similar import, constitute "forward looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors which may cause actual events to differ materially from expectations.  Such factors include those set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2015, including the following:

·	Technological, engineering, manufacturing, quality control or other circumstances that could delay the sale or shipment of products;

·	Economic, business, market and competitive conditions in the software industry and technological innovations that could affect the Company's business;

·	The Company's inability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on the proprietary rights of the Company; and

·	General economic and business conditions and the availability of sufficient financing.

Except as otherwise required by applicable laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, as a result of new information, future events or otherwise.

The following discussion and analysis should be read in conjunction with the Company's unaudited condensed consolidated financial statements and notes thereto included in Part 1, Item 1 of this quarterly report on Form 10-Q and "Management's Discussion and Analysis of Financial Condition and Results of Operations" set forth in the Company's Annual report on Form 10-K for the fiscal year ended December 31, 2015.

Overview

The Company is a leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective management of document-based transactions. iSign's solutions encompass a wide array of functionality and services, including electronic signatures, biometric authentication and simple-to-complex workflow management. These solutions are available across virtually all enterprise, desktop and mobile environments as a seamlessly integrated platform for both ad-hoc and fully automated transactions. iSign's platform can be deployed both on-premise and as a cloud-based service, with the ability to easily transition between deployment models.

The Company was incorporated in Delaware in October 1986. Except for the year ended December 31, 2004, in each year since its inception the Company has incurred losses. For the two-year period ended December 31, 2015, net losses attributable to common stockholders aggregated approximately $14,998, and, at June 30, 2016, the Company's accumulated deficit was approximately $129,395.

For the three months ended June 30, 2016, total revenue was $356, a decrease of $11, or 3%, compared to total revenue of $367 in the prior year period. For the six months ended June 30, 2016, total revenue was $633, a decrease of $181, or 22%, compared to total revenue of $814 in the prior year period. The decreases in revenue for the three months ended June 30, 2016 is due primarily to lower maintenance revenue. The decrease in revenue for the six months ended June 30, 2016 is due primarily to a decrease in engineering services revenue.

For the three months ended June 30, 2016, the loss from operations was $853, a decrease of $176, or 17%, compared with a loss from operations of $1,029 in the prior year period. The decrease in the loss for the three months ended June 30, 2016 was due primarily to cost reductions put in place beginning in the first quarter of 2016. For the six months ended June 30, 2016, the loss from operations was $1,995, a decrease of $52, or 3%, compared with a loss from operations of $2,047 in the prior year period. The decrease in the loss from operations for the six months ended June 30, 2016 is primarily attributable to cost reductions put in place beginning in the first quarter of 2016.

Other expense for the three months ended June 30, 2016, was $16, an increase of $16, compared to other expense of $0 in the prior year period. The increase in other expense for the three months ended June 30, 2016 was primarily due to a valuation allowance provided for the potential negative outcome of penalties for the late filing of certain tax forms related to foreign operations. For the six months ended June 30, 2016, other expense was $13, an increase of $13, compared to other expense of $0 in the prior year. The increase in other expense for the six months ended June 30, 2016 was primarily due to the factors discussed above for the three-month period.

Critical Accounting Policies and Estimates

 

Refer to Item 7, "Management Discussion and Analysis of Financial Condition and Results of Operations" in the Company's 2015 Form 10-K.

Effect of Recent Accounting Pronouncement

On February 25, 2016, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) 2016, Leases (Topic 842) intended to improve financial reporting about leasing transactions which requires companies to report capital and operating leases with a term of 12 Months or longer on their balance sheets. Disclosure requirements of the leasing arrangement will include qualitative and quantitative information about the amounts recorded in the financial statements.

Implementation of ASU 2016 is not expected to have a material impact on the Company's financial position, results of operations and cash flows.

Results of Operations

Revenue

For the three months ended June 30, 2016, product revenue was $164, an increase of $11, or 7%, compared to product revenue of $153 in the prior year period.  The increase in revenue is primarily attributable to an increase in product licensing in the quarter. For the three months ended June 30, 2016, maintenance revenue was $192, a decrease of $22, or 10%, compared to maintenance revenue of $214 in the prior year period. This decrease is primarily due to the non-renewal of two maintenance contracts entered into in prior years.

For the six months ended June 30, 2016, product revenue was $224, a decrease of $160, or 42%, compared to product revenue of $384 in the prior year period. The decrease in product revenue is primarily due to the lack of engineering service revenue compared to the prior year.  For the six months ended June 30, 2016, maintenance revenue was $409, a decrease of $21, or 5%, compared to maintenance revenue of $430 in the prior year period.  The decrease in maintenance revenue is primarily due to the factors discussed for the three month period above.

Cost of Sales

For the three months ended June 30, 2016, cost of sales was $102, an increase of $7, or 7%, compared to cost of sales of $95 in the prior year period. The increase in cost of sales was due to an increase in direct labor related to transactional and maintenance revenue generating contracts during the three months ended June 30, 2016, compared to the prior year period.

For the six months ended June 30, 2016, cost of sales was $272, an increase of $54, or 25%, compared to cost of sales of $218 in the prior year period. The increase in cost of sales was due to an increase in direct labor related to transactional and maintenance contracts, compared to the prior year period.

Operating expenses

Research and Development Expenses

For the three months ended June 30, 2016, research and development expense was $367, a decrease of $131, or 26%, compared to research and development expense of $498 in the prior year period.  Research and development expenses consist primarily of salaries and related costs, outside engineering, maintenance items, and allocated facilities expenses. The most significant factors in the $131 decrease was a $44, or 12%, decrease in total salaries and benefits due to the reduction of one engineer in the third quarter of the prior year together with a $46, or 54%, decrease in professional service expenses associated with product development. Other general expenses decreased $23, or 15%, compared to the prior year. Total expenses, before allocations for the three months ended June 30, 2016, were $483, a decrease of $112, or 19%, compared to $595 in the prior year period. The decrease in gross expenses is primarily due to the factors discussed above.

For the six months ended June 30, 2016, research and development expense was $685, a decrease of $336, or 33%, compared to research and development expense of $1,021 in the prior year period.  The most significant factors in the $336 decrease was a $109, or 15%, decrease in total salaries and benefits due to the reduction of one engineer in the third quarter of the prior year together with a $103, or 52%, decrease in professional service expenses associated with product development. Other general expenses decreased $58, or 18%, compared to the prior year. These expense reductions were augmented by an increase of $66, or 28%, in allocations out related to cost of sales and IT support compared to the prior year period.  Total expenses, before allocations to cost of sales, for the six months ended June 30, 2015, were $986, a decrease of $270, or 21%, compared to $1,256 in the prior year period.

Sales and Marketing Expense

For the three months ended June 30, 2016, sales and marketing expense was $127, a decrease of $115, or 48%, compared to sales and marketing expense of $242 in the prior year period. For the six months ended June 30, 2015, sales and marketing expense was $329, a decrease of $211, or 39%, compared to sales and marketing expense of $540 in the prior year period. These decreases were primarily attributable to salary and related cost savings implemented during the three months ended June 30, 2016 as part of the Company's transition to a go to market strategy principally focused on partner integrations.

General and Administrative Expense

For the three months ended June 30, 2016, general and administrative expense was $613, an increase of $52, or 9%, compared to general and administrative expense of $561 in the prior year period. The increase was primarily due to legal, accounting and other offering expenses that could not be brought forward and applied against the public offering that was completed in the second quarter of 2016. These expenses were offset by decreases in salaries and certain related expense, primarily stock-based compensation of $51, or 35%. Other general administrative expenses decreased $26, or 11%, compared to the prior year period.

For the six months ended June 30, 2016, general and administrative expense was $1,342, an increase of $260, or 24%, compared to general and administrative expense of $1,082 in the prior year period. The increase was primarily due to an increase in professional service expenses of $386, or 97%, related to legal, accounting and other offering expenses that could not be brought forward and applied against the public offering that was completed in the second quarter of 2016. The increase in professional services was partially offset by a decrease in salaries and related expense of $79, or 28%. The decrease in salaries and related expense is due primarily to the reduction in stock-based compensation expense, compared to the prior year period.

Other Income and Expense

For the three months ended June 30, 2016, interest expense was $68, an increase of $67, compared to interest expense of $1 in the prior year period. For the six months ended June 30, 2016, interest expense was $179, an increase of $178, compared to interest expense of $1 in the prior year period. The increase in interest expense is primarily due to the convertible notes and deferred compensation that were outstanding for the first five months of 2016, and converted into shares of Common Stock on May 19, 2016.

For the three months ended June 30, 2016, the gain on derivative liability was $149, an increase of $148, compared to the gain on derivative liability of $1 in the prior year period. For the six months ended June 30, 2016, the gain on derivative liability was $174, an increase of $157, compared to a gain on derivative liability of $17 in the prior year period. The increases in the gain on derivative liability was primarily due to the conversion of $1,068 of Short-term Debt in conjunction with the public offering and extinguishment of the related derivative liability in May 2016.

For the three months ended June 30, 2016, and 2015, there was no accretion of a beneficial conversion feature on the Company's Preferred Stock, respectively.

For the six months ended June 30, 2016, accretion of the beneficial conversion feature on the Company's Preferred Stock with a conversion price less than the closing market price of the Company's common stock on the issuance date for new issuances of Preferred Stock and for Preferred Share dividends was $245, a decrease of $282, or 54%, compared to $527 in the prior year period. The decrease is due to the absence of the sale of new Preferred shares and the conversion of all classes of Preferred Stock into common Stock on May 19, 2016. (see Liquidity and Capital Resources).

The Company recorded dividends in kind on shares of its Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock. For the three months ended June 30, 2016, dividends on shares of Preferred Stock were $459, a decrease of $326, or 42% compared to $785 in the prior year period. The decrease was due to the conversion of all classes of Preferred Stock into Common Stock on May 19, 2016.

For the six months ended June 30, 2016, dividends in kind on shares of Preferred Stock were $1,313, a decrease of $203, or 13%, compared to $1,516 in the prior year period. The decrease was due to the above mentioned conversion of all classes of Preferred Stock into Common Stock.

Liquidity and Capital Resources

At June 30, 2016, cash and cash equivalents totaled $455, compared to cash and cash equivalents of $846 at December 31, 2015. The decrease in cash was primarily due to net cash used in operating activities of $815. The use of cash was partially offset by the proceeds from the sale of Common Stock and Warrants during the six month period. At June 30, 2016, total current assets were $706, compared to total current assets of $1,312 at December 31, 2015. At June 30, 2016, the Company's principal sources of funds included its aggregated cash and cash equivalents of $455.

At June 30, 2016, accounts receivable net, was $196, an increase of $102, or 109%, compared to accounts receivable net of $94 at December 31, 2015. The increase is due primarily to the timing of billings during the three months ended June 30, 2016.

At June 30, 2016, prepaid expenses and other current assets were $55, a decrease of $317, or 85%, compared to prepaid expenses and other current assets of $372 at December 31, 2015. The decrease is due primarily to offsetting the prepaid financing expenses against the proceeds from the sale of Common Stock and Warrants in the second quarter of 2016.

At June 30, 2016, total current liabilities were $2,726, a decrease of $644, or 19%, compared to total current liabilities of $3,370 at December 31, 2015. At June 30, 2016, accounts payable was $1,331, an increase of $544, or 69%, from December 31, 2015. At June 30, 2016, accrued compensation was $297, an increase of $34, or 13%, compared to accrued compensation of $263 at December 31, 2015. The increases are due primarily to delays in the Company's fundraising efforts and to the amount of funding secured to date. Other accrued liabilities were $410, a decrease of $205, or 33%, from $615 at December 31, 2015 due to the conversion of $498 of deferred compensation including accrued interest into 286 shares of Common Stock. This reduction was offset by the accrual of additional professional services during the period. Short-term debt, net of the unamortized discount, decreased $801 or 81%, to $190 compared to $991 at December 31, 2015, due to the conversion of $1,068 of the notes plus accrued interest, into 683 shares of the Company's Common Stock.

Current deferred revenue was $339, a decrease of $45, or 12%, compared to current deferred revenue of $384 at December 31, 2015. Deferred revenue primarily reflects advance payments for maintenance fees from the Company's licensees that are generally recognized as revenue by the Company when all obligations are met or over the term of the maintenance agreement, whichever is longer. Deferred revenue is recorded when the Company receives advance payment from its customers.

For the three and six months ended June 30, 2016, the Company exercised its option to pay in kind the accrued dividends on Preferred Stock as follows:

On May 19, 2016, the Company closed an underwritten public offering of 690,000 shares of common stock at a public offering price of $1.74 per share. In addition, the Company sold 345,000 warrants, at a public offering price of $0.01 per warrant, to purchase shares of Common Stock. The warrants expire on May 18, 2021 and have an exercise price of $2.175 per share. The Company raised gross cash proceeds of $1,204 before deducting underwriting discounts and commissions and other offering expenses of $780. As a result of the consummation of the offering, each series of the Company's outstanding preferred stock, including accrued and unpaid dividends through May 19, 2016, were converted into shares of common stock.

The Company is using the funds received from the above financing for working capital and general corporate purposes.

The Company incurred $68 and $179, respectively, of interest expense for the three and six months ended June 30, 2016. The interest expense was related to the convertible notes and deferred compensation that were converted to Common Stock in May 2016.

The Company had the following material commitments as of June 30, 2016:

1.	The Company extended the lease on its offices in April 2010.  The base rent decreased by approximately 6% in November 2011 and will increase by approximately 3% per annum over the term of the new lease, which expires on October 31, 2016.

2.	The Company sublet approximately 3,000 feet of unutilized office space in August 2015.  The sub-lease will expire on October 31, 2016

The Company has experienced recurring losses from operations that raise a substantial doubt about its ability to continue as a going concern. There can be no assurance that the Company will have adequate capital resources to fund planned operations or that any additional funds will be available to it when needed, or if available, will be available on favorable terms or in amounts required by it. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern.

The Company did not enter into any short-term security investments during the three and six months ended June 30, 2016.

From time to time, the Company makes certain capital equipment or other purchases denominated in foreign currencies. As a result, the Company's cash flows and earnings are exposed to fluctuations in interest rates and foreign currency exchange rates. The Company attempts to limit these exposures through operational strategies and generally has not hedged currency exposures. During the three and six months ended June 30, 2016 and 2015, foreign currency translation gains and losses were insignificant.

Item 4. Controls and Procedures.

As of the end of the period covered by this report, we conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of our disclosure controls and procedures pursuant to paragraph (b) of Rule 13a-15 and 15d-15 under the Exchange Act of 1934 (the "Exchange Act"). Based on that evaluation our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to ensure that the information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

Our management, including our Chief Executive Officer and Chief Financial Officer, do not expect that our disclosure controls and procedures will prevent all errors or fraud. A control procedure, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control procedures are met. Because of the inherent limitations in all control procedures, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The Company considered these limitations during the development of its disclosure controls and procedures, and will continually reevaluate them to ensure they provide reasonable assurance that such controls and procedures are effective.

There has been no change in our internal control over financial reporting during the quarter ended June 30, 2016 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

None.

Not applicable.

None.

None.

Not applicable

None.

(a)

Exhibits.

 

 

 

*	Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.